DT Mobile and Samsung have resolved their patent disputes involving claims totaling RMB 123 million, according to an announcement made on August 29 by CICT Mobile, DT Mobile's parent company. The
) artificial intelligence deal with Samsung (005930.KS) also triggered scrutiny. EU antitrust regulators will seek additional third-party views, EU competition chief Margrethe Vestager said on Friday. The
Samsung Bioepis has failed to invalidate a second medical use patent for Janssen's blockbuster Stelara in the Netherlands. The District Court The Hague dismissed the revocation action, but the Korean
Swiss company Swatch Group has accused Samsung Electronics and its American subsidiary of infringing its trademark on designs for downloadable smartwatch faces. In the complaint, filed on Friday
The US International Trade Commission (USITC) has launched a section 337 investigation into Samsung concerning “certain mobile devices with multifunction emulators”. The complaint was originally